Over 80% of hepatocellular carcinoma (HCC) – the third-leading cause of cancer deaths globally – emerges from advanced liver fibrosis or cirrhosis. A comprehensive review in Hepatology International ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...

The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in hepatocellular carcinoma patients. Median progression-free survival was 8.3 months with ...

Aiming at a clinical characterization of patients with HCC in NCL, a retrospective analysis in a large single-center cohort in Germany was performed. Patients with HCC in NCL were compared to patients ...

A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a ...

The liver is an extremely sensitive organ. It filters blood, eliminates toxins and creates bile to digest food; without a functioning liver, a person will die. Its sensitive nature, however, makes it ...